Practice Location

2301 ERWIN RD
DURHAM, NC 27705-4699

Phone: (919) 684-3401

What does STEPHEN SKAPEK research?

Dr. Skapek studies various types of cancers that affect children, particularly those that are difficult to treat, like desmoid-type fibromatosis and embryonal rhabdomyosarcoma. He is focused on finding new ways to detect cancer early and exploring treatment options that may offer better outcomes for young patients. For example, he works on using ultrasound technology to find circulating tumor cells in blood, which can signal if cancer is spreading and needs attention. Additionally, he investigates the use of targeted therapies, such as tyrosine kinase inhibitors, to improve treatment effectiveness while reducing side effects for children with specific tumors.

Key findings

  • Developed a method using ultrasound and microbubbles to detect circulating tumor cells, aiding in the early identification of cancer, crucial for effective treatment.
  • Found that tyrosine kinase inhibitors could be more effective than standard treatments for children with desmoid-type fibromatosis, suggesting a shift in treatment strategy.
  • Identified targeting oxidative stress as a promising approach for treating embryonal rhabdomyosarcoma, which may lead to better outcomes in future therapies.

Frequently asked questions

Does Dr. Skapek study childhood cancers?
Yes, Dr. Skapek specializes in various pediatric cancers, including desmoid-type fibromatosis and embryonal rhabdomyosarcoma.
What new treatments has Dr. Skapek researched?
He has researched the use of tyrosine kinase inhibitors, which may be more effective for children with certain types of tumors.
How does Dr. Skapek's work help children with cancer?
His work improves early detection of cancer and explores new treatment options that could lead to better health outcomes for children.

Publications in plain English

A Novel Approach to Harnessing Acoustic A-Lines to Detect Circulating Tumor Cells in Flowing Blood.

2024

Nano letters

Kang S, Skapek S, Krishnan S, Gambhir SS, Zeng Y +2 more

Plain English
This study explored a new method for finding circulating tumor cells (CTCs) in blood using ultrasound and targeted microbubbles. The researchers created a specialized system that can detect unique sound patterns made by these microbubbles when they attach to CTCs. They found that the sound frequencies produced by these bound microbubbles can help identify different types of cancer, which is important for catching cancer spread early and improving patient care. Who this helps: This helps patients by enabling earlier detection of potentially spreading cancer.

PubMed

Rationale for the use of tyrosine kinase inhibitors in the treatment of paediatric desmoid-type fibromatosis.

2021

British journal of cancer

Sparber-Sauer M, Orbach D, Navid F, Hettmer S, Skapek S +5 more

Plain English
This study looks at a type of tumor called desmoid-type fibromatosis (DTF) in children, focusing on treatment options when the standard method of watchful waiting isn’t effective. Researchers found that while current treatments like vinblastine and methotrexate (VBL-MTX) are standard, tyrosine kinase inhibitors (TKIs) have shown to be more effective in adults and could potentially work better for kids too. Since TKIs like imatinib, pazopanib, and sorafenib might have fewer side effects and better results, it’s important to consider them for treating children, but their long-term safety and specific effects on kids should be studied further. Who this helps: This helps children with desmoid-type fibromatosis and their doctors.

PubMed

Targeting oxidative stress in embryonal rhabdomyosarcoma.

2013

Cancer cell

Chen X, Stewart E, Shelat AA, Qu C, Bahrami A +42 more

Plain English
This study looked at embryonal rhabdomyosarcoma (ERMS), a type of cancer that affects soft tissue and resembles developing muscle. Researchers found that ERMS has a lot of genetic changes linked to the RAS/NF1 pathway, making it riskier to treat. They discovered that targeting oxidative stress could be a promising treatment approach for this cancer. Who this helps: This research helps patients with embryonal rhabdomyosarcoma by identifying new treatment options.

PubMed

Frequent Co-Authors

Shu Kang Sunil Krishnan Sanjiv S Gambhir Yushun Zeng Qifa Zhou Raiyan Zaman Monika Sparber-Sauer Daniel Orbach Fariba Navid Simone Hettmer

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.